Blog

PLYMOUTH MEETING, PA [April 11, 2024] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted more than 1,700 oncology professionals during the NCCN 2024 Annual Conference on April 5-7. The yearly meeting includes opportunities for care providers to interact with world-renowned specialists

MIAMI (April 11, 2024) – Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with a new way to test individual drugs on tumor samples. The results of the clinical study were published today in Nature Medicine. This combined approach, developed

COLUMBUS, Ohio – Although lung cancer is traditionally thought of as a “smoker’s disease,” a surprising 15-20% of newly diagnosed lung cancers occur in people who have never smoked, many of whom are in their 40s or 50s.  Credit: The Ohio State University Comprehensive Cancer

“Our results reveal that MIA-602 may be a useful treatment for Doxorubicin-resistant AML […]” Credit: 2024 Gaumond et al. “Our results reveal that MIA-602 may be a useful treatment for Doxorubicin-resistant AML […]” BUFFALO, NY- April 10, 2024 – A new research paper was published

(MEMPHIS, Tenn. – April 10, 2024) Infection with the influenza virus leads to lung injury through inflammation over-activation that causes collateral damage to cells required for breathing. Such damage can be life-threatening, but scientists have a new preventative treatment. A team from St. Jude Children’s

Using artificial intelligence (AI) to supplement radiologists’ evaluations of mammograms may improve breast-cancer screening by reducing false positives without missing cases of cancer, according to a study by researchers at Washington University School of Medicine in St. Louis and Whiterabbit.ai, a Silicon Valley-based technology startup.

Philadelphia, April 10, 2024 – CAR T cell therapy has revolutionized the way certain types of cancer are treated, and the longer those CAR T cells live in a patient’s body, the more effectively they respond to cancer. Now, in a new study, researchers at

Researchers from Tokyo Medical and Dental University (TMDU) have developed a novel method for chemically modifying engineered messenger RNA molecules, allowing greater control of their biological functions and advancing mRNA therapeutic technologies Credit: Department of Advanced Nanomedical Engineering, TMDU Researchers from Tokyo Medical and Dental

RNA has long been considered only as a passive messenger in the cell, produced by DNA transcription to transfer genetic information to the protein factories, the ribosomes. However, it has turned out, that RNA does much more than that. In addition to the coding DNA

The hematopoietic system is a complex tissue characterized by multiple layers of stem cells, progenitor cells, and mature blood cells. Operating under normal conditions, it ensures a continuous and stable blood supply throughout the body. Genetic dysregulation of gene expression in hematopoietic stem cells (HSCs)